nach oben

Erschienen in:

01.11.2007 | Original Article

Randomized comparison of second trimester pregnancy termination utilizing saline moistened or dry misoprostol

verfasst von: Bulent Yilmaz, Sefa Kelekci, Ibrahim Egemen Ertas, Murat Ozel, Necdet Sut, Leyla Mollamahmutoglu, Nuri Danisman

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2007

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this randomized prospective study was to compare efficacy and side effects of saline moistened misoprostol with dry misoprostol, administered 800 μg intravaginally every 6 h up to a maximum of 3 doses in 24 h for second trimester pregnancy termination.

Materials and methods

A total of 81 women seeking termination of second trimester pregnancy (55 fetal death, 17 fetal structural anomaly, 5 chromosomal abnormality, 4 other reasons) were randomly assigned to one of two treatment groups: (1) intravaginal non-moistened (dry) misoprostol in group A (n = 40) or (2) misoprostol moistened with 3 ml of saline in group B (n = 41).

Results

All of the patients in either group aborted within 48 h (100% success rate). Delivery was achieved in a median (interquartile range) of 13 (40) h with the group A protocol and 12 (36) h with the group B protocol (P = 0.652). Delivery with first dose, delivery within 12 h and delivery within 24 h were similar (P > 0.05) in group B (34.1, 87.5 and 60%, respectively) and group A (25, 82.9, 46.3, respectively). Both treatment regimens were tolerable and with similar side effects.

Conclusion

Misoprostol moistened with saline was not more effective than dry misoprostol for second trimester pregnancy termination.

Ngai SW, Tang OS, Ho PC (2003) Prostaglandins for induction of second-trimester termination and intrauterine death (Review). Best Pract Res Clin Obstet Gynaecol 17:765–75 (review)PubMedCrossRef

Carbonell JL, Rodriguez J, Delgado E, Sanchez C, Vargas F, Valera L, Mari J, Valero F, Salvador I, Llorente M (2004) Vaginal misoprostol 800 microg every 12 h for second-trimester abortion. Contraception 70:55–60PubMedCrossRef

Goldberg AG, Greenberg MB, Darney PD (2001) Misoprostol and pregnancy. N Engl J Med 344:38–47PubMedCrossRef

Tang OS, Schweer H, Seyberth HW, Lee SWH, Ho PC (2002) Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 17:332–336PubMedCrossRef

Bygdeman M (2003) Pharmacokinetics of prostaglandins (Review). Best Pract Res Clin Obstet Gynaecol 17:707–716 (review)PubMedCrossRef

El-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A (1995) Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 13:983–987CrossRef

Ho PC, Ngai SW, Liu KL, Wong GC, Lee SW (1997) Vaginal misoprostol compared with oral misoprostol in termination of secondtrimester pregnancy. Obstet Gynecol 90:735–738PubMedCrossRef

Bebbington MW, Kent N, Lim K, Gagnon A, Delilse MF, Tessier F, Wilson RD (2002) A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination. Am J Obstet Gynecol 187:853–857PubMedCrossRef

Creinin MD, Moyer R, Guido R (1997) Misoprostol for medical evacuation of early pregnancy failure. Obstet Gynecol 89:768–772PubMedCrossRef

10.

Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD (1997) Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 90:88–92PubMedCrossRef

11.

Zalanyi S (1998) Vaginal misoprostol alone is effective in the treatment of missed abortion. BJOG 105:1026–1035CrossRef

12.

Jain JK, Mishell DR Jr (2001) Misoprostol regimens for termination of second trimester pregnancy. Hum Reprod 16:393PubMedCrossRef

13.

Li CF, Chan CW, Ho PC (2003) A comparison of isosorbide mononitrate and misoprostol cervical ripening before suction evacuation. Obstet Gynecol 102:583–588PubMedCrossRef

14.

Davis AR, Robilotto CM, Westhoff CL, Forman S, Zhang J (2004) NICHD Management of Early Pregnancy Failure Trial group, Bleeding patterns after vaginal misoprostol for treatment of early pregnancy failure. Hum Reprod 19:1655–1658PubMedCrossRef

15.

Creinin MD, Carbonell JLL, Scwartz JL (1999) A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotraxate for abortion. Contraception 59:11–16PubMedCrossRef

16.

Ngai SW, Tang OS, Ho PC (2000) Randomized comparison of vaginal (200 μg every 3 h) and oral (400 μg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy. Hum Reprod 15:2205–2208PubMedCrossRef

17.

Gilles JM, Creinin MD, Barnhart K, Westhoff C, Frederick MM, Zhang J (2004) National Institute of Child Health and Human Development Management of Early Pregnancy Failure Trial A randomized trial of saline solution-moistened misoprostol versus dry misoprostol for first-trimester pregnancy failure. Am J Obstet Gynecol 190:389–394PubMedCrossRef

18.

Feldman DM, Borgida AF, Rodis JF, Leo MV, Campbell WA (2003) A randomized comparison of two regimens of misoprostol for second-trimester pregnancy termination. Am J Obstet Gynecol 189:710–713PubMedCrossRef

19.

Yilmaz B, Kelekci S, Ertas IE, Kahyaoglu S, Ozel M, Sut N, Danisman N (2005) Misoprostol moistened with acetic acid or saline for second trimester pregnancy termination: a randomized prospective double-blind trial. Hum Reprod 20:3067–3071PubMedCrossRef

20.

Danielsson KG, Marions L, Rodriguez A, Spur BW, Wong PY, Bygdeman M (1999) Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol 93:275–280PubMedCrossRef

21.

Ficicioglu C, Tasdemir M, Tasdemir S (1996) Effect of vaginal misoprostol application for cervical softening in pregnancy interruption before ten weeks of gestation. Acta Obstet Gynecol Scand 75:54–56PubMed

22.

Singh K, Fong YF, Prasad RN, Dong F (1999) Does an acidic medium enhance the efficacy of vaginal misoprostol for pre-abortion cervical priming? Hum Reprod 14:1635–1637PubMedCrossRef

23.

Sanchez-Ramos L, Danner CJ, Delke I, Kaunitz AM (2002) The effect of tablet moistening on labor induction with intravaginal misoprostol: a randomized trial. Obstet Gynecol 99:1080–1084PubMedCrossRef

24.

Kelekci S, Yilmaz B, Savan K (2004) Misoprostol wetting with acetic acid for pre-abortion cervical priming. Int J Gynaecol Obstet 85:188–189PubMedCrossRef

25.

Mishell DR Jr, Jain JK, Byrne JD, Lacarra MD (1998) A medical method of early pregnancy termination using tamoxifen and misoprostol. Contraception 58:1–6PubMedCrossRef

26.

Wiebe ER (2001) Misoprostol administration in medical abortion. A comparison of three regimens. J Reprod Med 46:125–129PubMed

27.

Jain JK, Meckstroth KR, Mishell DR Jr (1999) Early pregnancy termination with intravaginally administered sodium chloride solution-moistened misoprostol tablets: historical comparison with mifepristone and oral misoprostol. Am J Obstet Gynecol 181:1386–1391PubMedCrossRef

28.

Jain JK, Meckstroth KR, Park M, Mishell DR Jr (1999) A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination. Contraception 60:353–356PubMedCrossRef

29.

Creinin MD, Vittinghoff E (1994) Methotrexate and misoprostol vs misoprostol alone for early abortion. A randomized controlled trial. JAMA 272:1190–1195PubMedCrossRef

30.

Ozeren M, Bilekli C, Aydemir V, Bozkaya H (1999) Methotrexate and misoprostol used alone or in combination for early abortion. Contraception 59:389–394PubMedCrossRef

31.

Carbonell JL, Varela L, Velazco A, Cabezas E, Fernandez C, Sanchez C (1998) Oral methotrexate and vaginal misoprostol for early abortion. Contraception 57:83–88PubMedCrossRef

32.

Carbonell Esteve JL, Varela L, Velazco A, Tanda R, Sanchez C (1999) 25 mg or 50 mg of oral methotrexate followed by vaginal misoprostol 7 days after for early abortion: a randomized trial. Gynecol Obstet Invest 47:182–187PubMedCrossRef

33.

ACOG Practice Bulletin (2001) Clinical management guidelines for obstetrician-gynecologists. Medical management of abortion Obstet Gynecol 97(Suppl):1–13

34.

Gunalp S, Bildirici I (2000) The effect of vaginal pH on the efficacy of vaginal misoprostol for induction of labor. Acta Obstet Gynecol Scand 79:283–285PubMedCrossRef

Titel: Randomized comparison of second trimester pregnancy termination utilizing saline moistened or dry misoprostol
verfasst von: Bulent Yilmaz
Sefa Kelekci
Ibrahim Egemen Ertas
Murat Ozel
Necdet Sut
Leyla Mollamahmutoglu
Nuri Danisman
Publikationsdatum: 01.11.2007
Verlag: Springer-Verlag
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 5/2007
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-007-0374-9

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Welche Übungen helfen gegen Diastase recti abdominis?

30.04.2024 Schwangerenvorsorge Nachrichten

Die Autorinnen und Autoren einer aktuellen Studie aus Griechenland sind sich einig, dass Bewegungstherapie, einschließlich Übungen zur Stärkung der Bauchmuskulatur und zur Stabilisierung des Rumpfes, eine Diastase recti abdominis postpartum wirksam reduzieren kann. Doch vieles ist noch nicht eindeutig belegt.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Abstract

Objective

Materials and methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2007

A rare occurrence of trisomy 18 and trisomy 21 in a dizygotic twin pregnancy

Three synchronized neoplasms of the female genital tract: an extraordinary presentation

Anthropometric measurements in the diagnosis of pelvic size: an analysis of maternal height and shoe size and computed tomography pelvimetric data

Once a cesarean always a cesarean? A computer-assisted decision analysis